AlterWAN, Inc. v. Amazon.com, Inc.

CourtDistrict Court, D. Delaware
DecidedMarch 15, 2021
Docket1:19-cv-01544
StatusUnknown

This text of AlterWAN, Inc. v. Amazon.com, Inc. (AlterWAN, Inc. v. Amazon.com, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
AlterWAN, Inc. v. Amazon.com, Inc., (D. Del. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

ALTERWAN, INC., ) ) Plaintiff, ) ) v. ) C.A. No. 19-1544 (MN) ) AMAZON.COM, INC. and ) AMAZON WEB SERVICES, INC., ) ) Defendants. )

MEMORANDUM ORDER

At Wilmington this 15th day of March 2021: IT IS HEREBY ORDERED that the claim terms of U.S. Patent Nos. 7,111,163 (“the ’163 patent”); 7,318,152 (“the ’152 patent”); 8,595,478 (“the ’478 patent”); 9,015,471 (“the ’471 patent”); and 9,667,534 (“the ’534 patent”) with agreed-upon constructions are construed as follows (see D.I. 116 at 1-2): 1. “guarantee” means “guarantees” (’163 Patent, claim 7). 2. “wherein the data packets includes” means “wherein the data packets include” (’478 Patent, claim 5). 3. “designation” means “destination” (’478 Patent, claim 27 & 57). 4. “private tunnel” means “data path through the internet from the source firewall to the destination firewall through the predefined, low hop count, high bandwidth path” (’152 Patent, claim 18; ’620 Patent, claims 1, 14 & 27). 5. “dedicated line” means “a line that must have sufficient bandwidth capacity to handle the worst case bandwidth consumption of the particular client facility it serves and must be dedicated and not dialup” (’471 Patent, claims 4 & 14; ’478 Patent, claims 53 & 63). Further, as announced at the hearing on February 5, 2021, IT IS HEREBY ORDERED that the disputed claim terms of the ’163, ’152, ’478, ’471, and ’534 Patents are construed as follows: 1. “encapsulating” means “packaging into a packet” (’163 Patent, claim 7; ’478 Patent, claim 31); “encapsulating” means “packaging into packets” (’478 Patent, claim 65; ’534 Patent, claims 1 & 8); “encapsulate” means “package into a packet” (’478 Patent, claims 35 & 60; ’471 Patent, claims 10 & 16); and “encapsulated” means “packaged into packets” (’534 Patent, claims 1). 2. “non-blocking bandwidth” means “bandwidth that will always be available and will always be sufficient” (’152 Patent, claims 1, 12, 15, 20 & 25; ’471 Patent, claims 1 & 14). 3. “cooperating service provider” and “cooperating third party service provider” means “service provider that agrees to provide blocked bandwidth” (’478 Patent, claims 1, 6, 18, 51 & 63; ’471 Patent, claim 2). 4. “minimized link cost” is corrected to read “minimum link cost” (’471 Patent, claim 7). The parties briefed the issues (see D.I. 101) and submitted an appendix containing both intrinsic and extrinsic evidence, including expert declarations (see D.I. 116). AlterWAN provided a tutorial describing the relevant technology. (See D.I. 99). The Court carefully reviewed all submissions in connection with the parties’ contentions regarding the disputed claim terms, heard oral argument and applied the following legal standards in reaching its decision: I. LEGAL STANDARDS A. Claim Construction “[T]he ultimate question of the proper construction of the patent [is] a question of law,” although subsidiary fact-finding is sometimes necessary. Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 837-38 (2015). “[T]he words of a claim are generally given their ordinary and customary meaning [which is] the meaning that the term would have to a person of ordinary skill in the art in question at the time of the invention, i.e., as of the effective filing date of the patent application.” Phillips v. AWH Corp., 415 F.3d 1303, 1312-13 (Fed. Cir. 2005) (en banc) (internal citations and quotation marks omitted). Although “the claims themselves provide substantial guidance as to the meaning of particular claim terms,” the context of the surrounding words of the claim also must be considered. Id. at 1314. “[T]he ordinary meaning of a claim term is its meaning to the ordinary artisan after reading the entire patent.” Id. at 1321 (internal quotation marks omitted). The patent specification “is always highly relevant to the claim construction analysis . . .

[as] it is the single best guide to the meaning of a disputed term.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996). It is also possible that “the specification may reveal a special definition given to a claim term by the patentee that differs from the meaning it would otherwise possess. In such cases, the inventor’s lexicography governs.” Phillips, 415 F.3d at 1316. “Even when the specification describes only a single embodiment, [however,] the claims of the patent will not be read restrictively unless the patentee has demonstrated a clear intention to limit the claim scope using words or expressions of manifest exclusion or restriction.” Hill-Rom Servs., Inc. v. Stryker Corp., 755 F.3d 1367, 1372 (Fed. Cir. 2014) (internal quotation marks omitted) (quoting Liebel-Flarsheim Co. v. Medrad, Inc., 358 F.3d 898, 906 (Fed. Cir. 2004)). In addition to the specification, a court “should also consider the patent’s prosecution

history, if it is in evidence.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 980 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370 (1996). The prosecution history, which is “intrinsic evidence, . . . consists of the complete record of the proceedings before the PTO [Patent and Trademark Office] and includes the prior art cited during the examination of the patent.” Phillips, 415 F.3d at 1317. “[T]he prosecution history can often inform the meaning of the claim language by demonstrating how the inventor understood the invention and whether the inventor limited the invention in the course of prosecution, making the claim scope narrower than it would otherwise be.” Id. In some cases, courts “will need to look beyond the patent’s intrinsic evidence and to consult extrinsic evidence in order to understand, for example, the background science or the meaning of a term in the relevant art during the relevant time period.” Teva, 135 S. Ct. at 841. Extrinsic evidence “consists of all evidence external to the patent and prosecution history,

including expert and inventor testimony, dictionaries, and learned treatises.” Markman, 52 F.3d at 980. Expert testimony can be useful “to ensure that the court’s understanding of the technical aspects of the patent is consistent with that of a person of skill in the art, or to establish that a particular term in the patent or the prior art has a particular meaning in the pertinent field.” Phillips, 415 F.3d at 1318. Nonetheless, courts must not lose sight of the fact that “expert reports and testimony [are] generated at the time of and for the purpose of litigation and thus can suffer from bias that is not present in intrinsic evidence.” Id. Overall, although extrinsic evidence “may be useful to the court,” it is “less reliable” than intrinsic evidence, and its consideration “is unlikely to result in a reliable interpretation of patent claim scope unless considered in the context of the intrinsic evidence.” Id. at 1318-19. Where the intrinsic record unambiguously describes the scope

of the patented invention, reliance on any extrinsic evidence is improper. See Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1308 (Fed. Cir. 1999) (citing Vitronics, 90 F.3d at 1583). B.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
Ecolab, Inc. v. FMC Corp.
569 F.3d 1335 (Federal Circuit, 2009)
Microsoft Corp. v. i4i Ltd. Partnership
131 S. Ct. 2238 (Supreme Court, 2011)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Chef America, Inc. v. Lamb-Weston, Inc.
358 F.3d 1371 (Federal Circuit, 2004)
Sandisk Corp. v. Kingston Technology Co., Inc.
695 F.3d 1348 (Federal Circuit, 2012)
Technology Licensing Corp. v. Videotek, Inc.
545 F.3d 1316 (Federal Circuit, 2008)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Hill-Rom Services, Inc. v. Stryker Corporation
755 F.3d 1367 (Federal Circuit, 2014)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
789 F.3d 1335 (Federal Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
AlterWAN, Inc. v. Amazon.com, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/alterwan-inc-v-amazoncom-inc-ded-2021.